Johnson & Johnson pays $2.2 billion for U.S. kickback, off-label settlement
Health care giant Johnson & Johnson will pay more than $2.2 billion to resolve criminal and civil claims arising from allegations of kickbacks to U.S. doctors and improper marketing claims about three of its prescription drugs.